J.Safra Asset Management Corp Merus N.V. Transaction History
J.Safra Asset Management Corp
- $1.54 Billion
- Q3 2025
A detailed history of J.Safra Asset Management Corp transactions in Merus N.V. stock. As of the latest transaction made, J.Safra Asset Management Corp holds 85 shares of MRUS stock, worth $8,027. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85
Previous 12
608.33%
Holding current value
$8,027
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MRUS
# of Institutions
223Shares Held
65.3MCall Options Held
311KPut Options Held
556K-
Paradigm Biocapital Advisors LP New York, NY4.28MShares$404 Million10.51% of portfolio
-
Rtw Investments, LP New York, NY4MShares$378 Million3.23% of portfolio
-
Wellington Management Group LLP Boston, MA3.73MShares$352 Million0.04% of portfolio
-
Commodore Capital LP New York, NY3.53MShares$333 Million17.29% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.38MShares$320 Million4.09% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $4.33B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...